|
⚲
|
| Keyboard |
| McElhaugh Michael J
✚
|
|
|---|---|
| CIK # | 0001635326 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001635326] | |
| 4 | [0001635326] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| McElhaugh Michael J | |
| Arbutus Biopharma Corp |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Arbutus Biopharma Corp ABUS
Stock Option (Right to Buy) · derivative
|
2025-02-14 | Grant | 718,800 | $0.00 | |
|
Arbutus Biopharma Corp ABUS
Common Shares
|
2025-02-14 | Grant | 177,000 | $0.00 | |
|
Arbutus Biopharma Corp ABUS
Common Shares
|
2025-02-04 | Sell | 23,790 | $3.28 | 78,031 |
|
Arbutus Biopharma Corp ABUS
Common Shares
|
2024-02-02 | Sell | 10,164 | $2.31 | 23,479 |
|
Arbutus Biopharma Corp ABUS
Common Shares
|
2024-02-01 | Grant | 123,800 | $0.00 | |
|
Arbutus Biopharma Corp ABUS
Stock Option (Right to Buy) · derivative
|
2024-02-01 | Grant | 495,100 | $0.00 | |
|
Arbutus Biopharma Corp ABUS
Common Shares
|
2023-02-01 | Grant | 83,700 | $0.00 | |
|
Arbutus Biopharma Corp ABUS
Stock Option (Right to Buy) · derivative
|
2023-02-01 | Grant | 334,700 | $0.00 | |
|
Arbutus Biopharma Corp ABUS
Stock Option (Right to Buy) · derivative
|
2022-01-20 | Grant | 325,850 | $2.81 | 915,638 |
|
Arbutus Biopharma Corp ABUS
Stock Options · derivative
|
2021-02-13 | Grant | 249,000 | $0.00 | |
|
Arbutus Biopharma Corp ABUS
Common Stock
|
2021-02-09 | Sell | 20,000 | $5.00 | 100,000 |
|
Arbutus Biopharma Corp ABUS
Common Stock
|
2020-12-14 | Sell | 30,000 | $5.00 | 150,000 |
|
Arbutus Biopharma Corp ABUS
Common Stock
|
2020-12-14 | Sell | 10,000 | $5.00 | 50,000 |
|
Arbutus Biopharma Corp ABUS
Common Stock
|
2020-07-23 | Sell | 20,000 | $5.01 | 100,200 |
|
Arbutus Biopharma Corp ABUS
Stock Options · derivative
|
2020-02-17 | Grant | 200,000 | $0.00 | |
|
Arbutus Biopharma Corp ABUS
Employee Stock Option (Right to Buy) · derivative
|
2019-03-01 | Grant | 104,500 | $0.00 |